Zobrazeno 1 - 10
of 87
pro vyhledávání: '"R E, Champlin"'
Autor:
F. Ong, F. Ravandi, U. Popat, T. M. Kadia, N. Daver, C. DiNardo, M. Konopleva, G. Borthakur, E. J. Shpall, B. Oran, G. Al-Atrash, R. Mehta, E. J. Jabbour, M. Yilmaz, G. C. Issa, G. Garcia-Manero, A. Maiti, H. A. Abbas, R. E. Champlin, N. J. Short
Publikováno v:
HemaSphere, Vol 6, Pp 465-466 (2022)
Externí odkaz:
https://doaj.org/article/be1d56ece7e148ed85fa6f968d2fd530
Autor:
V. Ho, R. F. Duarte, J.-J. Boelens, M. S. Cairo, R. E. Champlin, S. Giralt, M. Hamadani, C. S. Higham, J. H. Jerkins, J. Laurence, S. Mayer, R. Nakamura, O. Penack, M.-A. Perales, G. Rondón, M. Scordo, S. Hingorani, S. Vasu
Publikováno v:
HemaSphere, Vol 6, Pp 1229-1230 (2022)
Externí odkaz:
https://doaj.org/article/054aec8e162b47b0b4969357b9c8df26
Autor:
J Q, Guo, J Y, Lian, Y M, Xian, M S, Lee, A B, Deisseroth, S A, Stass, R E, Champlin, M, Talpaz, J Y, Wang, R B, Arlinghaus
Publikováno v:
Blood. 83:3629-3637
Chronic myelogenous leukemia (CML) is a myeloproliferative disorder associated with the Philadelphia chromosome (Ph1) in more than 95% of these patients. The Ph1 and the resulting BCR-ABL fused genes are markers for this type of leukemia. In CML, the
Publikováno v:
The Journal of Immunology. 150:5263-5269
We have found that fully functional CD56+CD3- NK cells can be generated from highly enriched populations of CD34+ human bone marrow progenitors in long term bone marrow culture (LTBMC) with IL-2. Strong lytic activity against K-562 cells was observed
Autor:
J L, Gajewski, L D, Petz, L, Calhoun, S, O'Rourke, E M, Landaw, N R, Lyddane, L A, Hunt, G J, Schiller, W G, Ho, R E, Champlin
Publikováno v:
Blood. 79:3076-3085
Hemolysis most commonly occurs following bone marrow transplant when there is “minor” ABO blood group incompatibility between donor and recipient. The hemolysis has been attributed to destruction of the patient's incompatible erythrocytes by dono
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation Society. 4(1)
Blood and marrow transplantation (BMT) is increasingly used to treat malignant and nonmalignant diseases. Despite significant advances in the management of transplant recipients, however, fungal infections remain important life-threatening complicati
Autor:
Y S, Kim, S N, Konoplev, F, Montemurro, E, Hoy, T L, Smith, G, Rondón, R E, Champlin, A A, Sahin, N T, Ueno
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7(12)
High-dose chemotherapy with autologous stem cell transplantation (HDCT) produces a high tumor response rate for patients with metastatic breast cancer and have 20% long-term progression-free survival. Overexpression of HER-2/neu oncoprotein predicts
Autor:
R, Gopal, C S, Ha, S L, Tucker, I F, Khouri, S A, Giralt, J L, Gajewski, B S, Andersson, J D, Cox, R E, Champlin
Publikováno v:
Cancer. 92(7)
Total body irradiation (TBI) is commonly used with autologous bone marrow transplantation (BMT) for treatment of hematologic malignancies. Pulmonary complications of TBI can cause long-term morbidity and mortality. The authors have compared the pulmo
Publikováno v:
British journal of haematology. 110(4)
This study evaluated the efficacy of allogeneic bone marrow transplantation (AlloBMT) in eight patients who had chronic lymphocytic leukaemia (CLL) in Richter's transformation. Five patients were in resistant relapse and three others were in sensitiv
Autor:
R E, Champlin, N, Schmitz, M M, Horowitz, B, Chapuis, R, Chopra, J J, Cornelissen, R P, Gale, J M, Goldman, F R, Loberiza, B, Hertenstein, J P, Klein, E, Montserrat, M J, Zhang, O, Ringdén, S C, Tomany, P A, Rowlings, M E, Van Hoef, A, Gratwohl
Publikováno v:
Blood. 95(12)
Peripheral blood cells are increasingly used in place of bone marrow as a source of hematopoietic stem cells for allogeneic transplantation. The relative efficacy of these 2 approaches is unknown. This retrospective multivariate analysis compared res